ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Twist Bioscience Earns 2022 Great Place to Work Certification

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has earned Great Place to Work® Certification™ in the U.S. for the second consecutive year, and for the first time in China, Germany, Singapore, and the United Kingdom.

Great Place to Work is the global authority on workplace culture, employee experience and the leadership behaviors proven to deliver market-leading revenue, employee retention and increased innovation. Great Place to Work Certification recognizes employers who create an outstanding employee experience and is based on employee feedback and independent analysis.

“The results of the Great Place to Work survey showed that 85% of employees say that Twist is a great place to work and 90% are proud to tell others that they work at Twist,” said Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience. “Our employees are our greatest asset and as Twist grows, we continue to intentionally take steps to strengthen our corporate culture and positive employee experience. This year we issued our first ESG report as a reflection of our commitment to building a diverse global workforce and inclusive work environment.”

“The average percentage of employees who say that their employer is a great workplace is 57% for a typical company in the U.S., making Twist well above average,” said Sarah Lewis-Kulin, vice president of global recognition at Great Place to Work. “Companies recognized with the Great Place to Work Certification show an ongoing commitment to employee experience.”

Twist offers employees development at all levels of the organization, diversity and cultural experiences, competitive compensation packages including comprehensive health and wellness benefits, equity in the company, robust family friendly policies including parental leave, paid time off to volunteer, and more. To learn more about working at Twist, please visit our Careers site. To learn more about Twist’s environmental, social and governance (ESG) efforts, please visit the ESG page of our website.

About Twist Bioscience Corporation

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.

Follow us on Twitter | Facebook | LinkedIn | YouTube

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  226.62
-0.14 (-0.06%)
AAPL  271.74
-0.45 (-0.16%)
AMD  207.94
+6.88 (3.42%)
BAC  54.80
+0.54 (0.99%)
GOOG  304.16
+0.41 (0.13%)
META  663.41
-1.04 (-0.16%)
MSFT  485.10
+1.12 (0.23%)
NVDA  178.60
+4.46 (2.56%)
ORCL  191.59
+11.56 (6.42%)
TSLA  482.42
-0.95 (-0.20%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.